HOME >> MEDICINE >> NEWS
Japanese doctors likelier than US counterparts to involve patients' families in decisions

Medical residents in Japan are more likely to involve patients' families in end-of-life decision making--and to favor informing family members over the patients first-- than their United States counterparts, who prefer dealing directly with the patient, according to a new study conducted by Dr. Bob Gabbay and colleagues.

Yet the Japanese medical residents are more conflicted about their approach compared with medical residents in the U.S.

The findings reflect cultural norms in the two countries, said lead researcher Baback B. Gabbay who was a fourth-year medical student at UCLA at the time the study was written. Family ties are stronger in Japan than in the U.S., where a tradition of individualism is more culturally ingrained. However, the degree of uncertainty in the responses of Japanese (medical?) residents may reflect changing cultural norms in Japan.

"Traditionally, the family in Japan usually decides what to tell the patient," Gabbay said. "It's different than in the United States, where the individual autonomy to make decisions is perceived as relatively more important."

"Negotiating End-of-Life Decision Making: A Comparison of Japanese and U.S. Residents' Approaches" is published in the July issue of Academic Medicine.

The researchers distributed surveys to 244 Japanese and 103 U.S. medical residents. Response rates were 74 percent for the Japanese residents and 71 percent among U.S. residents.

Among the findings:

  • 95 percent of Japanese residents said they would inform both patient and family about a metastatic cancer diagnosis, with 99 percent of that group reporting they would notify the family first. By contrast, 53 percent of U.S. residents said they would speak only with the patient and just 2 percent said they would inform the family first.

  • 72 percent of the Japanese residents said that both patient and family should be told a metastatic cancer prognosis, with 23 perce
    '"/>


Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
25-Jun-2005


Page: 1 2 3

Related medicine news :

1. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
2. Japanese adults with diabetes have increased cancer risk
3. Consumption of green tea associated with reduced mortality in Japanese adults
4. Japanese encephalitis widespread in Bali
5. One dose of vaccine against Japanese encephalitis provides sustained protection
6. 6 out of 10 doctors arent frustrated that patients cant lower cholesterol
7. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
8. New doctors test kit to help prevent debilitating osteoporosis
9. Italian doctors get their information on medicines from drug company sales reps
10. Approved medical resident hours still resulting in sleepy doctors
11. MTAS will cause irreparable harm to 10,000 junior doctors

Post Your Comments:
(Date:10/22/2014)... King of Prussia, PA (PRWEB) October 22, 2014 ... Group, is recognized as an industry leader with over ... industry award winning team leader in the areas related ... In addition, Mr. Carlson is an Editorial Advisory Board ... Group Healthcare Council Educator. Blue Fin Group is ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter , ... in vitro fertilization (IVF) are only about half as likely ... reproduction technique, new research indicates, and the racial disparity persists ... about 31 percent of white patients became pregnant after IVF, ... more than 4,000 IVF cycles over two years to tease ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... crucial part of conventional in vitro fertilization (IVF) -- the ... take place in a device inside the vagina, new research ... that the device, called an INVOcell, might sharply cut costs ... make the technology more accessible to those who don,t live ...
(Date:10/22/2014)... By Dennis Thompson HealthDay ... freelance cameraman who was diagnosed with Ebola while working for ... system and can leave the special isolation unit at Nebraska Medical ... two weeks, the hospital said Tuesday. A blood test confirmed ... Ashoka Mukpo, 33, can head home to Providence, R.I., NBC ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is offering ... a damaged mitral valve as the heart continues to ... Abbott Vascular , is designed to treat degenerative ... which the heart’s mitral valve leaflets fail to close ... left ventricle into the left atrium. The heart must ...
Breaking Medicine News(10 mins):Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
(Date:10/22/2014)... , Oct. 22, 2014  Paper Pak ... has developed APLS ® Body Guard Bio, ... the spread of bacteria and virus while protecting ... Body Guard Bio features a rugged, external nylon ... that create a leak-proof inner chamber that contains ...
(Date:10/22/2014)... 2014 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral ... results from its Phase IIa clinical trial of ... treat type 1 diabetes. The trial was conducted in ... a U.S. Food and Drug Administration (FDA) Investigational ...
(Date:10/22/2014)... 22, 2014   Surefire Medical , Inc., the ... to maximize targeted delivery of embolization agents in minimally ... oncologist John R. Daniels , MD of the ... surgical oncologist Steven C. Katz , MD of ... Scientific Advisory Board (SAB).    "The role ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
Cached News: